# Trade Mark Journal No.2026/002 9 January 2026

## WO0000001890417 (5)

Office of origin: United States of America

Date of International Registration:5 November 2025
Date of designation in the UK: 5 November 2025

International priority date claimed: 5 May 2025 (United States of America) (99170293)

Class 5
  Pharmaceutical preparations for the treatment of erythropoietic porphyria (EPP), X-linked protoporphyria (XLPP), genetic diseases and disorders, dermatological diseases and disorders, hematological diseases and disorders, liver diseases and disorders, and photosensitivity.

Disc Medicine, Inc.

Representative: Christina M. Licursi Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210-2206, UNITED STATES OF AMERICA